.png)
Where Science Meets Strategy. And Strategy Serves Purpose.
An exclusive forum for senior decision-makers navigating the future of therapeutic innovation.
learn more
Previous DDIF Attendees Include:
AB Science
Almirall, S.A
Amgen
Angelini
Arvinas
Astex Pharmaceuticals
AstraZeneca
Bayer
Bicycle Therapeutics
Boehringer Ingelheim
Bristol Myers Squibb
Byondis
Carbon Logic Biotech
Centogene
Centre for Drug Design and Discovery (CD3)
Charles River Laboratories
Charm Therapeutics
Confo Therapeutics
Crescendo Biologics
Eisai
EMBL-EBI
Evox Therapeutics
Fierce Unicorn
Fisher Friedman IP Group
Freie Universitat Berlin
Galapagos NV
Genmab
Genome Biologics
Gilead Sciences
GlaxoSmithKline
Goethe-Universitat Hospital
Heath Innovation Research Alliance
Hubrecht Organoid Technology
IRCCS San Raffaele
Janssen (Johnson & Johnson)
Laudea Research GmbH
Leibniz Institute for Farm Animal Biology
Leibniz Institute for Molecular Pharmacology (FMP)
Leiden University
LEO Pharma
Lhasa Limited
Lonza
Lygature
Max Delbruck Center
Max Planck Institute
Medibiofarma S.L.
Merck Group
Merck Sharp & Dohme (MSD)
Neurocrine Biosciences
Novartis
Parkinson's UK
Pfizer
Pharmablock
Radboud University Nijmegen
Roche
Sosei Heptares
Storm Therapeutics
Symeres
Technische Universitat Berlin
Tehran Polytechnic
TroplQ Health Sciences
Univercity Medicine Berlin
University of Groningen
University of Jerusalem
Vertex Pharmaceuticals
-
CSOs, CTOs, Heads of R&D
-
VPs/Directors of Drug Discovery,
-
Director / Head of High-Throughput Screening (HTS)
-
Director of Translational Biology / Cell Biology
-
Head of Computational Biology / AI in Drug Discovery
-
Procurement and Business Development
-
Innovation/Strategy Units
-
Pharmaceutical
-
Biotech Companies
-
Academic & Research Institutions
-
Contract Research Organisations (CROs)
-
Government & Public Health Agencies
-
Investors & Tech Scouts
Building Connections
Discover what C-suite executives, scientists, and innovators are saying about our summits — impromptu interviews and first-hand experiences from leaders driving the future of drug discovery and beyond.
Private Data Protection Disclaimer At GBX Events we are committed to safeguarding the privacy and confidentiality of all our attendees, especially given the seniority and strategic roles of participants at this event. To protect the integrity of our community and the personal data of C-suite executives and senior decision-makers, we do not publicly publish attendee lists. This ensures that your information remains secure, and that you are not subject to unsolicited outreach or misuse of your professional identity. All attendee information is handled with the highest level of discretion and is used solely for essential event-related communications, personalized scheduling, and secure on-site logistics. Data is processed in full compliance with applicable privacy regulations, including the GDPR. By joining our event, you’re entering a trusted environment built on confidentiality, mutual respect, and purposeful connection. For more information, please contact - hello@gbx-events.com
